{"id":3893,"date":"2024-02-18T18:26:58","date_gmt":"2024-02-18T18:26:58","guid":{"rendered":"http:\/\/drhimanshuyadav.com\/benefits-and-risks-of-antibiotics-for-appendicitis-uw-medicine\/"},"modified":"2024-02-18T18:26:58","modified_gmt":"2024-02-18T18:26:58","slug":"benefits-and-risks-of-antibiotics-for-appendicitis-uw-medicine","status":"publish","type":"post","link":"https:\/\/drhimanshuyadav.com\/blog\/benefits-and-risks-of-antibiotics-for-appendicitis-uw-medicine\/","title":{"rendered":"Benefits and risks of antibiotics for appendicitis – UW Medicine"},"content":{"rendered":"
\n

Antibiotics may be a good choice for some, but not all, patients with appendicitis, according to results from the Comparing Outcomes of Antibiotics and Appendectomy (CODA) trial. Reported today in the New England Journal of Medicine<\/a><\/strong>.<\/p>\n

“About 3 out of 10 patients in the antibiotic group ultimately underwent appendectomy within 90 days,” he said. david frum<\/a>, co-principal investigator and professor and associate chair of surgery at the University of Washington School of Medicine. \u201cEach treatment has advantages and disadvantages, and patients will value these treatments differently based on their unique characteristics, concerns, and perspectives.\u201d<\/p>\n

coda<\/a> This is the largest clinical randomized trial of appendicitis treatment in history. At hospitals in 14 states, 1,552 appendicitis patients agreed to participate and were randomly assigned to receive antibiotics first or appendectomy. <\/p>\n

Almost half of the patients in the antibiotic group were discharged from the emergency department and avoided hospitalization for initial treatment, although the overall time spent in hospital was similar in both groups.<\/p>\n

“Patients treated with antibiotics had more frequent emergency department visits, but they missed less time from work or school,” said Bonnie Bizzell, chair of the CODA Patient Advisory Committee. \u201cSuch information could be important as individuals consider the most appropriate treatment for their circumstances. The CODA trial captures these measures for shared decision-making regarding appendicitis. This is actually the first of its kind in this type of test.\u201d<\/p>\n

“When we compared the results of people treated with antibiotics alone to those who had appendectomies, we found that people who received either treatment felt better within 30 days.” said lead researcher Dr. David Taran, professor of emergency medicine and medicine. \/Infectious Diseases at the David Geffen School of Medicine, University of California, Los Angeles. “In terms of overall health, antibiotics are no worse than surgery, and most people were able to avoid surgery in the short term,” Taran said.<\/p>\n

[Download the soundbites below of Dr. Giana Davidson discussing the CODA Trial<\/a>.]<\/strong><\/p>\n